2025-01-01 2025-12-31 false Capium Accounts Production 1.1 14602638 2025-01-01 2025-12-31 14602638 bus:FullAccounts 2025-01-01 2025-12-31 14602638 bus:FRS102 2025-01-01 2025-12-31 14602638 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 14602638 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 14602638 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14602638 2025-01-01 2025-12-31 14602638 2025-12-31 14602638 bus:RegisteredOffice 2025-01-01 2025-12-31 14602638 core:WithinOneYear 2025-12-31 14602638 core:AfterOneYear 2025-12-31 14602638 1 2025-01-01 2025-12-31 14602638 bus:Director1 2025-01-01 2025-12-31 14602638 bus:Director1 2025-12-31 14602638 bus:Director1 2024-01-01 2024-12-31 14602638 2024-01-01 14602638 bus:LeadAgentIfApplicable 2025-01-01 2025-12-31 14602638 2024-01-01 2024-12-31 14602638 2024-12-31 14602638 core:WithinOneYear 2024-12-31 14602638 core:AfterOneYear 2024-12-31 14602638 bus:EntityAccountantsOrAuditors 2024-01-01 2024-12-31 14602638 core:FurnitureFittings 2025-01-01 2025-12-31 14602638 core:FurnitureFittings 2025-12-31 14602638 core:FurnitureFittings 2024-12-31 14602638 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-12-31 14602638 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 14602638 core:CostValuation core:Non-currentFinancialInstruments 2025-12-31 14602638 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 14602638 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-12-31 14602638 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 14602638 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 14602638 core:Non-currentFinancialInstruments 2025-12-31 14602638 core:Non-currentFinancialInstruments 2024-12-31 14602638 core:ShareCapital 2025-12-31 14602638 core:ShareCapital 2024-12-31 14602638 core:RetainedEarningsAccumulatedLosses 2025-12-31 14602638 core:RetainedEarningsAccumulatedLosses 2024-12-31 14602638 dpl:Item1 2025-01-01 14602638 dpl:Item1 2025-12-31 14602638 dpl:Item1 2024-01-01 14602638 dpl:Item1 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 14602638
KLINIKO AESTHETICS LIMITED
Unaudited Financial Statements
Period of accounts Start date: 01 January 2025 End date: 31 December 2025

KLINIKO AESTHETICS LIMITED Contents Page For the year ended 31 December 2025
Director's report | 1
Statement of financial position | 2
Notes to the financial statements | 3

KLINIKO AESTHETICS LIMITED Director's Report For the year ended 31 December 2025
Director's report and financial statements The director presents his/her/their annual report and the financial statements for the year ended 31 December 2025. Principal activities Principal activity of the company during the financial year was of Hairdressing and other beauty treatment Director The director who served the company throughout the year was as follows:
Melda ERDOGAN
Statement of director's responsibilities The director is responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice. Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the director is required to : select suitable accounting policies and then apply them consistently make judgements and accounting estimates that are reasonable and prudent state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions On behalf of the board.
---------------------------------- Melda ERDOGAN Director
Date approved: 06 April 2026 1

KLINIKO AESTHETICS LIMITED Statement of Financial Position As at 31 December 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 3,852 |  | 2,715
|  | 3,852 |  | 2,715
Current assets |  |  |
Cash at bank and in hand |  | 2,358 |  | 3,172
Creditors: amount falling due within one year | 4 | (818) |  | (1,011)
Net current assets |  | 1,540 |  | 2,161
Total assets less current liabilities |  | 5,392 |  | 4,876
Creditors: amount falling due after more than one year | 5 | (9,155) |  | (9,955)
Net assets |  | (3,763) |  | (5,079)
Capital and reserves |  |  |
Called up share capital |  | 1 |  | 1
Profit and loss account |  | (3,764) |  | (5,080)
Shareholders' funds |  | (3,763) |  | (5,079)
For the year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. The financial statements were approved by the director on 06 April 2026 and were signed by:
------------------------------- Melda ERDOGAN Director
2

KLINIKO AESTHETICS LIMITED Notes to the Financial Statements For the year ended 31 December 2025
General Information KLINIKO AESTHETICS LIMITED is a private company, limited by shares, registered in , registration number 14602638, registration address 643 HIGH ROAD, TOTTENHAM LONDON, N17 8AA. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: Stocks Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
2. | Average number of employees Average number of employees during the year was 2 (2024 : 0).
3. | Tangible fixed assets
Cost or valuation | Fixtures and Fittings |  | Total
| £ |  | £
At 01 January 2025 | 3,358 |  | 3,358
Additions | 2,026 |  | 2,026
Disposals | - |  | -
At 31 December 2025 | 5,384 |  | 5,384
Depreciation
At 01 January 2025 | 644 |  | 644
Charge for year | 888 |  | 888
On disposals | - |  | -
At 31 December 2025 | 1,532 |  | 1,532
Net book values
Closing balance as at 31 December 2025 | 3,852 |  | 3,852
Opening balance as at 01 January 2025 | 2,715 |  | 2,715
4. | Creditors: amount falling due within one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
PAYE & Social Security | 69 |  | 69
Other Creditors | 749 |  | 942
| 818 |  | 1,011
5. | Creditors: amount falling due after more than one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Directors' Loan Accounts | 9,155 |  | 9,955
| 9,155 |  | 9,955
3